Antitumorigenic effect of brain proline rich polypeptide-1 in human chondrosarcoma

Neurochemical Research

Volumn 34, Issue 12, 2009, Pages 2117-2121

  Galoian, Karina ^a   Scully, Sean ^a   McNamara, George ^a   Flynn, Patrick ^a   Galoyan, Armen ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b H Buniatian Institute of Biochemistry National Academy of Sciences of Armenia   (Armenia)

Author keywords

Cell cycle; Chondrosarcoma; CMyc; Hypothalamus; Proline rich polypeptide 1

Indexed keywords

MYC PROTEIN; POLYPEPTIDE; PROLINE; PROLINE RICH POLYPEPTIDE 1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL COUNT; CELL CYCLE PROGRESSION; CHONDROSARCOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE INACTIVATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; ONCOGENE MYC; PRIORITY JOURNAL; TUMOR CELL;

BONE NEOPLASMS; CELL LINE, TUMOR; CHONDROSARCOMA; GENES, MYC; HUMANS; PEPTIDES;

BOVINAE;

EID: 70450285405     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-009-0009-6     Document Type: Article

References (25)

1. Galoyan AA (2004) Brain neurosecretory cytokines: immune response and neuronal survival. Kluwer Academic/Plenum Publishers, NY
2. Armen Galoyan (2008) In: Abel Lajtha (ed) Handbook of neurochemistry and neurobiology, Springer, pp 155-196
3. AA Galoyan SL Grigorian CV Badalyan 2006 Treatment and prophylaxis of anthrax by brain neurosecretory cytokines Neurochem Res 31 6 795 803 10.1007/s11064-006-9082-2 10.1007/s11064-006-9082-2 1:CAS:528: DC%2BD28Xnt1aitLs%3D 16804761 (Pubitemid 44114813)
4. AA Galoyan JS Sarkissian VA Chavushyan, et al. 2005 Neuroprotective action of hypothalamic peptide PRP-1 at various time survival following spinal cord hemisection Neurochem Res 30 4 507 525 10.1007/s11064-005-2686-0 10.1007/s11064-005-2686-0 1:CAS:528:DC%2BD2MXlvVemuro%3D 16076021 (Pubitemid 40933659)
5. AA Galoyan 2000 Neurochemistry of brain neuroendocrine immune system: signal molecules Neurochem Res 25 9/10 1343 1355 10.1023/A:1007656431612 10.1023/A:1007656431612 1:CAS:528:DC%2BD3cXns1eitbo%3D 11059805
6. AA Galoyan VS Aprikyan 2002 A new hypothalamic polypeptide is a regulator of myelopoiesis Neurochem Res 27 4 305 312 10.1023/A:1014959212651 10.1023/A:1014959212651 1:CAS:528:DC%2BD3sXjsFGi 11958532 (Pubitemid 34273572)
7. AA Galoyan VA Shakhlamov LI Kondakova VI Altukhova GP Polyakova 2001 The influence of proline-rich polypeptide on the morphology and mitotic activity of neurinoma Hassel node of tumor cells at rats (electron microscopic investigations) PNAS (Russian Academy of Sciences) 101 2 279 286
8. 929 under PRP effect in vitro Med Sci Armenia 41 1 25 29
9. GM Simonyan AK Nersesyan RM Simonyan MA Babayan MA Simonyan AA Galoyan 2005 Antitumor and antistressor effects of hypothalamic proline rich peptide (PRP-1) in sarcoma 45; possible biochemical mechanisms Neurochemistry (RAS and NAS RA) 22 2 125 130
10. K Galoian S Scully A Galoyan 2009 Myc-oncogene inactivating effect by proline rich polypeptide (PRP-1) in chondrosarcoma JJ012 Cells Neurochem Res 34 2 379 385 10.1007/s11064-008-9794-6 1:CAS:528:DC%2BD1MXpvFWluw%3D%3D 18612811
11. Dean W. Felsher (2008) Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit? Cancer Res 68(9):3081-3086
12. CM Shachaf DW Felsher 2005 Tumor dormancy and Myc inactivation: pushing cancer to the brink of normalcy Cancer Res 65 4471 4474 10.1158/0008-5472.CAN- 05-1172 1:CAS:528:DC%2BD2MXks1Ohtrg%3D 15930260 (Pubitemid 40740778)
13. BJ Driker M Talpaz DJ Resta, et al. 2001 Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia N Engl J Med 344 1031 1037 10.1056/NEJM200104053441401 (Pubitemid 32267972)
14. DW Felsher 2003 Cancer revoked: oncogenes as therapeutic targets Nat Rev Cancer 3 375 378 10.1038/nrc1070 1:CAS:528:DC%2BD3sXjtlalsrc%3D 12724735 (Pubitemid 37328857)
15. DW Felsher Nicole Bradon 2003 Pharmacological Inactivation of MYC for the treatment of cancer Drug News Perspect 16 6 370 374 10.1358/dnp.2003.16.6. 829309 1:CAS:528:DC%2BD3sXosFyrs7c%3D 12973448 (Pubitemid 37221190)
16. KA Galoian N Garamszegi S Garamszegi SP Scully 2007 Molecular mechanism of tenascin C action on matrix metalloproteinase-1 invasive potential Exp Biol Med 232 4 515 522 1:CAS:528:DC%2BD2sXmt1Orurc%3D
17. YC Liu F Li J Handler CR Huang Y Xiang N Neretti JM Sedivy KI Zeller CV Dang 2008 Global regulation of nucleotide biosynthetic genes by c-Myc PLoS ONE 3 7 e2722 10.1371/journal.pone.0002722 18628958 (Jul 16)
18. 1 phase progression J Biol Chem 277 34 31263 31269 10.1074/jbc.M202528200 1:CAS:528: DC%2BD38XmsF2jsbo%3D 12070150 (August 23) (Pubitemid 34970835)
19. CH Wu J van Riggelen A Yetil AC Fan P Bachireddy DW Felsher 2007 Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation Proc Natl Acad Sci U S A 104 32 13028 13033 10.1073/pnas.0701953104 1:CAS:528:DC%2BD2sXpt1Krtbo%3D 17664422 (Pubitemid 351737587)
20. CH Wu J van Riggelen A Yetil AC Fan P Bachireddy WD Felsher 2007 Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation PNAS 104 32 13028 13033 10.1073/pnas.0701953104 1:CAS:528:DC%2BD2sXpt1Krtbo%3D 17664422 (Pubitemid 351737587)
21. R Funayama F Ishikawa 2007 Cellular senescence and chromatin structure Chromosoma 116 5 431 440 10.1007/s00412-007-0115-7 17579878 (Pubitemid 47456911)
22. HB Tey HE Khoo CH Tan 1992 Adenosine modulates cell growth in human epidermoid carcinoma (A431) cells Biochem Biophys Res Commun 187 3 1486 1492 10.1016/0006-291X(92)90470-6 1:CAS:528:DyaK38XmtV2kurg%3D 1417825 (Sep 30)
23. G Croiset D De Wied 1997 Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system Brain Res 759 1 18 23 10.1016/S0006-8993(97)00070-X 1:CAS:528:DyaK2sXjtlWgurw%3D 9219858 (Jun 6) (Pubitemid 27286339)
24. P Gandolfo C Patte J Leprince JL Rego AG Mensah-Nyagan H Vaudry MC Tonon 2000 The triakontatetraneuropeptide (TTN) stimulates thymidine incorporation in rat astrocytes through peripheral-type benzodiazepine receptors J Neurochem 75 (2 701 707 10.1046/j.1471-4159.2000.0750701.x 1:CAS:528:DC%2BD3cXltFCltLg%3D 10899945 (Pubitemid 30485451)
25. AV Schally AM Comaru-Schally A Plonowski A Nagy G Halmos Z Rekasi 2000 Peptide analogs in the therapy of prostate cancer Prostate 45 158 166 10.1002/1097-0045(20001001)45:2<158::AID-PROS10>3.0.CO;2-K 1:CAS:528:DC%2BD3cXnsFGisrc%3D 11027415 (Pubitemid 30747163)